Helen DeVos Children's Hospital
14
2
5
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
29%
4 trials in Phase 3/4
22%
2 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs
Role: collaborator
24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAs
Role: collaborator
Testicular Tissue Cryopreservation for Fertility Preservation
Role: collaborator
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
Role: collaborator
Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL
Role: collaborator
Pediatric Obesity Weight Evaluation Registry (POWER) Study
Role: collaborator
Healthy Weight for Teens
Role: collaborator
Study of the Use of Coated Venous Catheters in the Critically Ill Child
Role: collaborator
RCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies
Role: collaborator
The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children
Role: collaborator
Psychological Effects of Bone Marrow Transplants in Children
Role: collaborator
Study of Fluid Collection of the Chest in Children With Pneumonia
Role: collaborator
Managing Patient Expectations in Pediatric Weight Management
Role: collaborator
The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis
Role: collaborator
All 14 trials loaded